GlassScriptPhysician profile
Christina Lopez
NPI 1093973695
$463.68
in general payments reported to CMS, 2019-2025
10 companies · $338 in 2025
The $338 reported for 2025 was more than what 82% of Pediatric Critical Care Medicine providers received nationally (typical 2025 total: $71.68).
See the full distribution for Pediatric Critical Care Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $57.22 · 2024: $68.69 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $168.85 | 2023-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Sanofi-Aventis U.S. LLC | $53.21 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $44.78 | 2025 | Neffy |
| Phadia US INC. | $40.63 | 2023-2025 | Immunocap |
| Cranial Technologies, INC | $37.96 | 2025 | Doc Band |
| Alk-Abello, INC | $32.34 | 2025 | Neffy |
| Seqirus USA INC | $27.34 | 2025 | Flucelvax |
| Corium, LLC | $22.12 | 2025 | Azstarys |
| Pfizer INC. | $18.64 | 2025 | |
| Aimmune Therapeutics, INC. | $17.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.